Evidence map›Paper›PMID 34170972›Full record

ArticlePloS one2021

Harnessing clinical annotations to improve deep learning performance in prostate segmentation.

Karthik V Sarma, Alex G Raman, Nikhil J Dhinagar, Alan M Priester, Stephanie Harmon, Thomas Sanford, Sherif Mehralivand, Baris Turkbey, Leonard S Marks, Steven S Raman and 2 more

Abstract read
In one paragraph

Article in PloS one, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Karthik V SarmaUniversity of California, Los Angeles, Los Angeles, CA, United States of America.ORCID 0000-0002-7442-9526
Alex G RamanUniversity of California, Los Angeles, Los Angeles, CA, United States of America.
Nikhil J DhinagarUniversity of California, Los Angeles, Los Angeles, CA, United States of America.
Alan M PriesterUniversity of California, Los Angeles, Los Angeles, CA, United States of America.
Stephanie HarmonNational Cancer Institute, National Institutes of Health, Bethesda, MD, United States of America.
Thomas SanfordNational Cancer Institute, National Institutes of Health, Bethesda, MD, United States of America.
Sherif MehralivandNational Cancer Institute, National Institutes of Health, Bethesda, MD, United States of America.
Baris TurkbeyNational Cancer Institute, National Institutes of Health, Bethesda, MD, United States of America.
Leonard S MarksUniversity of California, Los Angeles, Los Angeles, CA, United States of America.
Steven S RamanUniversity of California, Los Angeles, Los Angeles, CA, United States of America.
William SpeierUniversity of California, Los Angeles, Los Angeles, CA, United States of America.
Corey W ArnoldUniversity of California, Los Angeles, Los Angeles, CA, United States of America.

Funding

Women's CancersP30CA016042 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Samuel Wheeler French · 1985 to 2026
$134.5M
UCLA SPORE IN PROSTATE CANCERP50CA092131 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI REITER, ROBERT E · 2002 to 2023
$42.6M
UCLA-Caltech Medical Scientist Training ProgramT32GM008042 · NIGMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI AJIJOLA, OLUJIMI A, DAWSON, DAVID WAYNE · 1985 to 2023
$29.9M
Medical Imaging Informatics Training GrantT32EB016640 · NIBIB · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ALEX BUI, William Hsu · 2013 to 2026
$2.3M
Biopsy Tracking and MRI Fusion to Enhance Imaging of Cancer Within the ProstateR01CA158627 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI MARKS, LEONARD STEPHEN · 2011 to 2013
$1.4M
Imaging, image guided biopsy and treatment of prostate cancerZIABC012062 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI TÜRKBEY, BARIS · 2021 to 2025
$1.3M
Prospective Assessment of Image Registration for the Diagnosis of Prostate CancerR01CA195505 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI MARKS, LEONARD STEPHEN · 2015 to 2016
$705k
Predicting the Presence of Clinically Significant Prostate Cancer using Multiparametric MRI and MR-US Fusion BiopsyR21CA220352 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ARNOLD, COREY WELLS · 2018 to 2019
$352k
Development of a Multimodal Deep Learning Model for the Generation of Cancer Probability Maps and Imaging Biomarkers for Prostate Cancer using Multiparametric MRIF30CA210329 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI SARMA, KARTHIK VENKATARAMAN · 2016 to 2022
$173k
CCR NIH HHS HHSN261200800001CNCI NIH HHS F30 CA210329NCI NIH HHS HHSN261200800001ENCI NIH HHS P30 CA016042NCI NIH HHS P50 CA092131NCI NIH HHS R01 CA158627NCI NIH HHS R01 CA195505NCI NIH HHS R21 CA220352NIBIB NIH HHS T32 EB016640NIGMS NIH HHS T32 GM008042
6 · The paper itself

Abstract

purposeDeveloping large-scale datasets with research-quality annotations is challenging due to the high cost of refining clinically generated markup into high precision annotations. We evaluated the direct use of a large dataset with only clinically generated annotations in development of high-performance segmentation models for small research-quality challenge datasets. MATERIALS AND

methodsWe used a large retrospective dataset from our institution comprised of 1,620 clinically generated segmentations, and two challenge datasets (PROMISE12: 50 patients, ProstateX-2: 99 patients). We trained a 3D U-Net convolutional neural network (CNN) segmentation model using our entire dataset, and used that model as a template to train models on the challenge datasets. We also trained versions of the template model using ablated proportions of our dataset, and evaluated the relative benefit of those templates for the final models. Finally, we trained a version of the template model using an out-of-domain brain cancer dataset, and evaluated the relevant benefit of that template for the final models. We used five-fold cross-validation (CV) for all training and evaluation across our entire dataset.

resultsOur model achieves state-of-the-art performance on our large dataset (mean overall Dice 0.916, average Hausdorff distance 0.135 across CV folds). Using this model as a pre-trained template for refining on two external datasets significantly enhanced performance (30% and 49% enhancement in Dice scores respectively). Mean overall Dice and mean average Hausdorff distance were 0.912 and 0.15 for the ProstateX-2 dataset, and 0.852 and 0.581 for the PROMISE12 dataset. Using even small quantities of data to train the template enhanced performance, with significant improvements using 5% or more of the data.

conclusionWe trained a state-of-the-art model using unrefined clinical prostate annotations and found that its use as a template model significantly improved performance in other prostate segmentation tasks, even when trained with only 5% of the original dataset.

Indexed as

Databases, FactualData CurationDeep LearningTomography, X-Ray ComputedHumansMaleProstateRetrospective Studies

Identifiers

PMID34170972
PMCPMC8232529

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.